Molecular Brain

unofficial impact factor 3.79

Open Access Research

Abnormalities in brain structure and behavior in GSK-3alpha mutant mice

Oksana Kaidanovich-Beilin1, Tatiana V Lipina1, Keizo Takao3,4,2,5, Matthijs van Eede6, Satoko Hattori4,2,5, Christine Laliberté6, Mustafa Khan1, Kenichi Okamoto9,1, John W Chambers7, Paul J Fletcher9,7, Katrina MacAulay1, Bradley W Doble8, Mark Henkelman9,6, Tsuyoshi Miyakawa3,4,2,5, John Roder9,1 and James R Woodgett9,1*

Author Affiliations

1 Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada

2 Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake 470-1192, Japan

3 Genetic Engineering and Functional Genomics Group, Frontier Technology Center, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan

4 Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Kawaguchi, Japan

5 Section of Behavior Analysis, Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, Okazaki, Japan

6 Mouse Imaging Center, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada

7 Center for Addiction and Mental Health, Toronto, Canada

8 McMaster Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON L8N 3Z5, Canada

9 University of Toronto, Departments of Medical Biophysics, Psychology, Psychiatry and Molecular & Medical Genetics, Toronto, ON M5S 1A1, Canada

For all author emails, please log on.

Molecular Brain 2009, 2:35 doi:10.1186/1756-6606-2-35

Published: 19 November 2009

Abstract

Background

Glycogen synthase kinase-3 (GSK-3) is a widely expressed and highly conserved serine/threonine protein kinase encoded by two genes that generate two related proteins: GSK-3α and GSK-3β. Mice lacking a functional GSK-3α gene were engineered in our laboratory; they are viable and display insulin sensitivity. In this study, we have characterized brain functions of GSK-3α KO mice by using a well-established battery of behavioral tests together with neurochemical and neuroanatomical analysis.

Results

Similar to the previously described behaviours of GSK-3β+/-mice, GSK-3α mutants display decreased exploratory activity, decreased immobility time and reduced aggressive behavior. However, genetic inactivation of the GSK-3α gene was associated with: decreased locomotion and impaired motor coordination, increased grooming activity, loss of social motivation and novelty; enhanced sensorimotor gating and impaired associated memory and coordination. GSK-3α KO mice exhibited a deficit in fear conditioning, however memory formation as assessed by a passive avoidance test was normal, suggesting that the animals are sensitized for active avoidance of a highly aversive stimulus in the fear-conditioning paradigm. Changes in cerebellar structure and function were observed in mutant mice along with a significant decrease of the number and size of Purkinje cells.

Conclusion

Taken together, these data support a role for the GSK-3α gene in CNS functioning and possible involvement in the development of psychiatric disorders.